10-Q: RF Acquisition Corp III Reports Q3 2026 Results, Announces Business Combination

RF Acquisition Corp III filed its Form 10-Q for the quarter ended June 30, 2026, detailing its financial status and announcing a significant business combination agreement with HCC Healthcare Pte. Ltd.

Summary

• RF Acquisition Corp III (RF III) has filed its quarterly report for the period ending June 30, 2026.
• The company, a blank check company, has not yet commenced operations and is focused on identifying and completing a business combination.
• RF III reported a net income of $566,737 for the three months ended June 30, 2026, and $1,239,770 for the nine months ended June 30, 2026.
• The company's primary source of income is interest earned on its Trust Account.
• A significant development is the July 9, 2026, announcement of a Business Combination Agreement with HCC Healthcare Pte. Ltd. and its subsidiary, HCC Merger Sub Limited.
• This business combination involves a recapitalization of HCC Healthcare and a merger of RF III with Merger Sub, making Merger Sub a subsidiary of HCC Healthcare.
• The total equity value of HCC Healthcare is set at $500,000,000 on a fully-diluted basis.
• The company had $891,600 in cash and $101,273,496 in its Trust Account as of June 30, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it reports expected financial performance for a SPAC and, more importantly, announces a significant step towards its business combination goal.

Positives

• Achieved net income of $566,737 for the three months ended June 30, 2026, and $1,239,770 for the nine months ended June 30, 2026, primarily from interest income.
• Successfully entered into a Business Combination Agreement with HCC Healthcare Pte. Ltd., a significant step towards its objective.
• Maintained a substantial balance in the Trust Account ($101,273,496 as of June 30, 2026) to fund the business combination.
• The company has sufficient funds for working capital needs within the next year.

Negatives

• As a blank check company, RF III has not generated any operating revenues and has no current operations.
• The company is subject to all risks associated with early-stage and emerging growth companies.
• The business combination is subject to various closing conditions, including shareholder approvals and regulatory requirements, with no guarantee of completion.
• Significant offering costs were incurred, including underwriting fees and the fair value of founder shares.

Risks

• The company may have insufficient funds to operate its business prior to completing a business combination if estimated costs exceed available funds.
• The business combination is subject to numerous closing conditions and regulatory approvals, and there is no assurance it will be completed.
• Geopolitical instability and market volatility could adversely affect the search for a business combination and the target business.
• The company's ability to complete a business combination is limited by a 21-month combination period, after which it will cease operations and liquidate if a combination is not achieved.

Future Outlook

The company's primary focus is on completing its business combination with HCC Healthcare Pte. Ltd. The success of this combination is contingent upon meeting various closing conditions, including shareholder approvals and regulatory requirements. If the business combination is not completed within the specified timeframe, the company will liquidate.

Management Comments

• Management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
• Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statement.
• Disclosure controls and procedures were effective as of June 30, 2026.

Industry Context

StockSavvy.ai notes that RF Acquisition Corp III operates within the Special Purpose Acquisition Company (SPAC) sector, which is characterized by its focus on identifying and merging with private companies to take them public. The announcement of a business combination agreement with HCC Healthcare Pte. Ltd. is a critical milestone for any SPAC, indicating progress towards its primary objective. The valuation of HCC Healthcare at $500 million suggests a mid-to-large-sized target for a SPAC of this size.

Comparison to Industry Standards

• The structure of the business combination, involving a recapitalization and merger, is a common approach for SPACs to integrate with target companies.
• The valuation of HCC Healthcare at $500 million on a fully-diluted basis is a key metric for assessing the deal's attractiveness relative to similar transactions in the deep technology and healthcare sectors.
• The SPAC market typically requires a business combination to be completed within 18-24 months; RF Acquisition Corp III has a 21-month window, which is within the standard range.

Legal Proceedings

• None disclosed.

Related Party Transactions

• The Sponsor (Alfa 30 Limited) received Founder Shares and provided a promissory note.
• The Sponsor and EarlyBirdCapital, Inc. (EBC) purchased Private Placement Units.
• An administrative service fee of $10,000 per month is paid to the Sponsor.
• The Sponsor or its affiliates may provide Working Capital Loans, which may be convertible into units.

Stakeholder Impact

• Shareholders: The business combination agreement is a critical event that will determine the future value of their investment. If the combination fails, shareholders may receive a pro-rata portion of the trust account.
• Sponsor: The success of the business combination is crucial for the Sponsor's investment and potential returns.
• Creditors: The company has obligations to creditors, including potential claims against the trust account if a business combination is not completed.

Next Steps

• Complete the business combination with HCC Healthcare Pte. Ltd., subject to closing conditions and approvals.
• If the business combination is not completed within the 21-month period, the company will cease operations, redeem public shares, and liquidate.
• Management will continue to identify and evaluate potential target businesses for a business combination.

Key Dates

Recommendation

The filing indicates progress towards a business combination, which is a positive development for a SPAC. However, the transaction is still subject to closing conditions and regulatory approvals, making it premature to recommend a strong buy or sell. A 'hold' recommendation reflects the current stage of development, awaiting successful completion of the business combination.

Keywords

RF Acquisition Corp III, SPAC, Business Combination, HCC Healthcare, Form 10-Q, Quarterly Report, Merger, Trust Account